Beijing InnoCare Pharma Tech Co., Ltd.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Beijing China (2001)

Organization Overview

First Clinical Trial
2017
NCT03189017
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beijing InnoCare Pharma Tech Co., Ltd. | Innocare Pharma Australia Pty Ltd